By A Mystery Man Writer
Recombinant vesicular stomatitis virus as an HIV-1 vaccine vector
A Recombinant Vesicular Stomatitis Virus Ebola Vaccine
Optimized intramuscular immunization with VSV-vectored spike protein triggers a superior immune response to SARS-CoV-2
Frontiers Pseudotyped Vesicular Stomatitis Virus-Severe Acute Respiratory Syndrome-Coronavirus-2 Spike for the Study of Variants, Vaccines, and Therapeutics Against Coronavirus Disease 2019
The viruses used in this study. The glycoproteins used are dia- grammed
Microorganisms, Free Full-Text
Pseudotyped Vesicular Stomatitis Virus-Severe Acute Respiratory Syndrome-Coronavirus-2 Spike for the Study of Variants, Vaccines, and Therapeutics Against Coronavirus Disease 2019 - Frontiers
Safe and effective two-in-one replicon-and-VLP minispike vaccine for COVID-19: Protection of mice after a single immunization
Waning humoral immune response to the BNT162b2 vaccine in heart transplant recipients over 6 months - American Journal of Transplantation
Structure of the Vesicular Stomatitis Virus L Protein in Complex with Its Phosphoprotein Cofactor - ScienceDirect
Neutralizing Antibody and Soluble ACE2 Inhibition of a Replication-Competent VSV-SARS-CoV-2 and a Clinical Isolate of SARS-CoV-2 - ScienceDirect
Neutralizing activity of Sputnik V vaccine sera against SARS-CoV-2 variants
JCI - Recombinant vesicular stomatitis virus–vectored vaccine induces long-lasting immunity against Nipah virus disease
Frontiers Development and Applications of VSV Vectors Based on Cell Tropism
A stable human-derived packaging cell line for production of high titer retrovirus/vesicular stomatitis virus G pseudotypes, (NAS Colloquium) Genetic Engineering of Viruses and Viral Vectors